A1353950
AZD-9291mesylate , 99% , 1421373-66-1
CAS NO.：1421373-66-1
Empirical Formula: C28H33N7O2.CH4O3S
Molecular Weight: 595.713
MDL number: MFCD28137994
EINECS: 200-064-1
| Pack Size | Price | Stock | Quantity |
| 10mg | RMB375.20 | In Stock |
|
| 50mg | RMB1119.20 | In Stock |
|
| 100mg | RMB1599.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >232°C (dec.) |
| storage temp. | -20°C Freezer, Under inert atmosphere |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| color | Off-White to Yellow |
| InChIKey | FUKSNUHSJBTCFJ-UHFFFAOYSA-N |
| SMILES | S(O)(=O)(=O)C.CN1C2=CC=CC=C2C(C2C=CN=C(NC3C=C(NC(=O)C=C)C(N(C)CCN(C)C)=CC=3OC)N=2)=C1 |
Description and Uses
Osimertinib is active against exon 19 deletions, exon 21 mutations, and also the exon 20 T790M mutations. It is preferentially selective for mutated EGFR, and therefore toxicity at therapeutic doses is lower than for first- and second-generation agents. Notably, osimertinib is able to cross the blood-brain barrier, making it active against disease in the CNS.
Osimertinib mesylate (AZD9291) is the mesylate form of osimertinib, which is an oral, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug.
Safety
| Symbol(GHS) |    GHS08,GHS07,GHS09 |
| Signal word | Danger |
| Hazard statements | H317-H372-H410-H400-H361-H302 |
| Precautionary statements | P201-P202-P281-P308+P313-P405-P501-P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P260-P264-P270-P314-P501-P264-P270-P301+P312-P330-P501-P273-P391-P501-P273-P391-P501 |
| HS Code | 29339900 |
